US9474282B2 - Acid-solubilized copper-ammonium complexes and copper-zinc-ammonium complexes, compositions, preparations, methods, and uses - Google Patents
Acid-solubilized copper-ammonium complexes and copper-zinc-ammonium complexes, compositions, preparations, methods, and uses Download PDFInfo
- Publication number
- US9474282B2 US9474282B2 US14/106,676 US201314106676A US9474282B2 US 9474282 B2 US9474282 B2 US 9474282B2 US 201314106676 A US201314106676 A US 201314106676A US 9474282 B2 US9474282 B2 US 9474282B2
- Authority
- US
- United States
- Prior art keywords
- copper
- ammonium
- water
- zinc
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 207
- ZURAKLKIKYCUJU-UHFFFAOYSA-N copper;azane Chemical class N.[Cu+2] ZURAKLKIKYCUJU-UHFFFAOYSA-N 0.000 title claims abstract description 45
- SWPHIVWCPLHNDF-UHFFFAOYSA-N N.[Cu+2].[Zn+2] Chemical class N.[Cu+2].[Zn+2] SWPHIVWCPLHNDF-UHFFFAOYSA-N 0.000 title claims abstract description 22
- 238000000034 method Methods 0.000 title claims description 6
- 238000002360 preparation method Methods 0.000 title abstract description 5
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 38
- 239000006071 cream Substances 0.000 claims abstract description 8
- 239000003814 drug Substances 0.000 claims abstract description 7
- 239000004599 antimicrobial Substances 0.000 claims abstract description 6
- 239000000344 soap Substances 0.000 claims abstract 3
- 239000010949 copper Substances 0.000 claims description 194
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 69
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 63
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 53
- 229910052802 copper Inorganic materials 0.000 claims description 53
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 49
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 34
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 32
- 229960001763 zinc sulfate Drugs 0.000 claims description 30
- 239000012153 distilled water Substances 0.000 claims description 22
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 claims description 20
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 19
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 16
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims description 15
- 239000001099 ammonium carbonate Substances 0.000 claims description 15
- 239000002253 acid Substances 0.000 claims description 13
- 239000000908 ammonium hydroxide Substances 0.000 claims description 11
- 235000012501 ammonium carbonate Nutrition 0.000 claims description 10
- 150000003863 ammonium salts Chemical class 0.000 claims description 10
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 6
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 claims description 5
- 235000012538 ammonium bicarbonate Nutrition 0.000 claims description 5
- 230000002195 synergetic effect Effects 0.000 claims description 5
- 239000008367 deionised water Substances 0.000 claims description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims 8
- 150000003751 zinc Chemical class 0.000 claims 4
- 235000005074 zinc chloride Nutrition 0.000 claims 4
- 239000011592 zinc chloride Substances 0.000 claims 4
- 235000011114 ammonium hydroxide Nutrition 0.000 claims 3
- 239000000470 constituent Substances 0.000 claims 3
- PTVDYARBVCBHSL-UHFFFAOYSA-N copper;hydrate Chemical compound O.[Cu] PTVDYARBVCBHSL-UHFFFAOYSA-N 0.000 claims 3
- 229910021641 deionized water Inorganic materials 0.000 claims 2
- 239000003599 detergent Substances 0.000 claims 2
- 239000006260 foam Substances 0.000 claims 2
- 229940113601 irrigation solution Drugs 0.000 claims 2
- 239000002674 ointment Substances 0.000 claims 2
- 239000008213 purified water Substances 0.000 claims 2
- 238000001223 reverse osmosis Methods 0.000 claims 2
- 239000004476 plant protection product Substances 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 9
- 208000015181 infectious disease Diseases 0.000 abstract description 7
- 241000233866 Fungi Species 0.000 abstract description 5
- 241000700605 Viruses Species 0.000 abstract description 4
- 230000000699 topical effect Effects 0.000 abstract description 4
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 239000007921 spray Substances 0.000 abstract description 2
- -1 wash Substances 0.000 abstract description 2
- 229940126534 drug product Drugs 0.000 abstract 1
- 230000007613 environmental effect Effects 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- TVZPLCNGKSPOJA-UHFFFAOYSA-N copper zinc Chemical compound [Cu].[Zn] TVZPLCNGKSPOJA-UHFFFAOYSA-N 0.000 description 109
- 229910017518 Cu Zn Inorganic materials 0.000 description 103
- 229910017752 Cu-Zn Inorganic materials 0.000 description 103
- 229910017943 Cu—Zn Inorganic materials 0.000 description 103
- 239000000243 solution Substances 0.000 description 36
- 239000000499 gel Substances 0.000 description 34
- 230000000694 effects Effects 0.000 description 32
- 241000186427 Cutibacterium acnes Species 0.000 description 29
- 230000002401 inhibitory effect Effects 0.000 description 19
- 230000002538 fungal effect Effects 0.000 description 18
- 230000001580 bacterial effect Effects 0.000 description 16
- 241000222122 Candida albicans Species 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 15
- 239000011701 zinc Substances 0.000 description 15
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 14
- 229910052725 zinc Inorganic materials 0.000 description 14
- 229920001817 Agar Polymers 0.000 description 13
- 241000588724 Escherichia coli Species 0.000 description 13
- 239000008272 agar Substances 0.000 description 13
- 210000004927 skin cell Anatomy 0.000 description 13
- 239000011550 stock solution Substances 0.000 description 13
- 208000002874 Acne Vulgaris Diseases 0.000 description 12
- 244000034356 Aframomum angustifolium Species 0.000 description 12
- 241001237548 Hymenoscyphus fraxineus Species 0.000 description 12
- 206010000496 acne Diseases 0.000 description 12
- 238000009472 formulation Methods 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 11
- 241000221204 Cryptococcus neoformans Species 0.000 description 11
- 235000019400 benzoyl peroxide Nutrition 0.000 description 11
- 238000010790 dilution Methods 0.000 description 11
- 239000012895 dilution Substances 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 230000005764 inhibitory process Effects 0.000 description 10
- 230000001717 pathogenic effect Effects 0.000 description 10
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- 244000144927 Aloe barbadensis Species 0.000 description 8
- 235000002961 Aloe barbadensis Nutrition 0.000 description 8
- 239000012980 RPMI-1640 medium Substances 0.000 description 8
- 241000352457 Shivajiella indica Species 0.000 description 8
- 235000011399 aloe vera Nutrition 0.000 description 8
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 8
- VQJMAIZOEPPELO-KYGIZGOZSA-N (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-(2-hydroxy-5-methylhexan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol hydrochloride Chemical compound Cl.CO[C@]12CC[C@@]3(C[C@@H]1C(C)(O)CCC(C)C)[C@H]1Cc4ccc(O)c5O[C@@H]2[C@]3(CCN1CC1CC1)c45 VQJMAIZOEPPELO-KYGIZGOZSA-N 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 7
- 229940094313 clearasil Drugs 0.000 description 7
- 231100000135 cytotoxicity Toxicity 0.000 description 7
- 230000003013 cytotoxicity Effects 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 239000001965 potato dextrose agar Substances 0.000 description 7
- 241000228245 Aspergillus niger Species 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000007792 addition Methods 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 150000001879 copper Chemical class 0.000 description 6
- 229910001431 copper ion Inorganic materials 0.000 description 6
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 230000000843 anti-fungal effect Effects 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 231100000433 cytotoxic Toxicity 0.000 description 5
- 230000001472 cytotoxic effect Effects 0.000 description 5
- 238000000386 microscopy Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 239000006150 trypticase soy agar Substances 0.000 description 5
- 229920001285 xanthan gum Polymers 0.000 description 5
- IOOMXAQUNPWDLL-UHFFFAOYSA-N 2-[6-(diethylamino)-3-(diethyliminiumyl)-3h-xanthen-9-yl]-5-sulfobenzene-1-sulfonate Chemical compound C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S(O)(=O)=O)C=C1S([O-])(=O)=O IOOMXAQUNPWDLL-UHFFFAOYSA-N 0.000 description 4
- 239000004342 Benzoyl peroxide Substances 0.000 description 4
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 4
- 241000221785 Erysiphales Species 0.000 description 4
- 208000031888 Mycoses Diseases 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 229940095731 candida albicans Drugs 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 229960004889 salicylic acid Drugs 0.000 description 4
- 239000000230 xanthan gum Substances 0.000 description 4
- 229940082509 xanthan gum Drugs 0.000 description 4
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 3
- 241000588626 Acinetobacter baumannii Species 0.000 description 3
- 241001225321 Aspergillus fumigatus Species 0.000 description 3
- 208000035143 Bacterial infection Diseases 0.000 description 3
- 201000007336 Cryptococcosis Diseases 0.000 description 3
- 241000588747 Klebsiella pneumoniae Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 244000000004 fungal plant pathogen Species 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000005063 solubilization Methods 0.000 description 3
- 230000007928 solubilization Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 244000291564 Allium cepa Species 0.000 description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 201000008225 Klebsiella pneumonia Diseases 0.000 description 2
- 208000005230 Leg Ulcer Diseases 0.000 description 2
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 2
- 208000007027 Oral Candidiasis Diseases 0.000 description 2
- 206010035717 Pneumonia klebsiella Diseases 0.000 description 2
- PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 2
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000005388 borosilicate glass Substances 0.000 description 2
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 235000012055 fruits and vegetables Nutrition 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229960003085 meticillin Drugs 0.000 description 2
- PGZUMBJQJWIWGJ-ONAKXNSWSA-N oseltamivir phosphate Chemical compound OP(O)(O)=O.CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1 PGZUMBJQJWIWGJ-ONAKXNSWSA-N 0.000 description 2
- 244000000003 plant pathogen Species 0.000 description 2
- 239000004302 potassium sorbate Substances 0.000 description 2
- 235000010241 potassium sorbate Nutrition 0.000 description 2
- 229940069338 potassium sorbate Drugs 0.000 description 2
- 229940055019 propionibacterium acne Drugs 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000011686 zinc sulphate Substances 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000588625 Acinetobacter sp. Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 241001480060 Blumeria Species 0.000 description 1
- 239000005739 Bordeaux mixture Substances 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 241001133184 Colletotrichum agaves Species 0.000 description 1
- 239000005751 Copper oxide Substances 0.000 description 1
- 229910021592 Copper(II) chloride Inorganic materials 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 241001536358 Fraxinus Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000004898 Herpes Labialis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 101000740455 Klebsiella pneumoniae Metallo-beta-lactamase type 2 Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 241000589242 Legionella pneumophila Species 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 241001291474 Malassezia globosa Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 239000005807 Metalaxyl Substances 0.000 description 1
- 208000037942 Methicillin-resistant Staphylococcus aureus infection Diseases 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000383295 Notholithocarpus densiflorus Species 0.000 description 1
- 206010067152 Oral herpes Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 241000219998 Philenoptera violacea Species 0.000 description 1
- 241000233622 Phytophthora infestans Species 0.000 description 1
- 241000370518 Phytophthora ramorum Species 0.000 description 1
- 206010035718 Pneumonia legionella Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 239000012979 RPMI medium Substances 0.000 description 1
- 206010037742 Rabies Diseases 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 239000012871 anti-fungal composition Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000656 anti-yeast Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 238000012458 antifungal assay Methods 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229940091771 aspergillus fumigatus Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 229910000431 copper oxide Inorganic materials 0.000 description 1
- BERDEBHAJNAUOM-UHFFFAOYSA-N copper(I) oxide Inorganic materials [Cu]O[Cu] BERDEBHAJNAUOM-UHFFFAOYSA-N 0.000 description 1
- LBJNMUFDOHXDFG-UHFFFAOYSA-N copper;hydrate Chemical compound O.[Cu].[Cu] LBJNMUFDOHXDFG-UHFFFAOYSA-N 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 244000052637 human pathogen Species 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 229940115932 legionella pneumophila Drugs 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- ZQEIXNIJLIKNTD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate Chemical compound COCC(=O)N(C(C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-UHFFFAOYSA-N 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000017066 negative regulation of growth Effects 0.000 description 1
- 210000003300 oropharynx Anatomy 0.000 description 1
- 229960002194 oseltamivir phosphate Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 201000010740 swine influenza Diseases 0.000 description 1
- 229940061367 tamiflu Drugs 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- RZLVQBNCHSJZPX-UHFFFAOYSA-L zinc sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O RZLVQBNCHSJZPX-UHFFFAOYSA-L 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
- A01N59/20—Copper
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/02—Sulfur; Selenium; Tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
- A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/16—Foams
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/02—Ammonia; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/50—Treatment of water, waste water, or sewage by addition or application of a germicide or by oligodynamic treatment
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
- C02F2103/42—Nature of the water, waste water, sewage or sludge to be treated from bathing facilities, e.g. swimming pools
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- This invention relates generally to compositions with antimicrobial activity, and more specifically to compositions containing acid-solubilized copper-ammonium or acid-solubilized copper-zinc-ammonium complexes as active ingredients.
- the Greeks. Romans and Aztecs used copper metal or its compounds for the treatment of chronic infections and for hygiene in general. For example, in the Hippocratic Collection copper is recommended for the treatment of leg ulcers associated with varicose veins. To prevent infection of fresh wounds, the Greeks sprinkled a dry powder composed of copper oxide and copper sulfate on the wound. Another antiseptic wound treatment at the time was a boiled mixture of honey and red copper oxide. The Greeks had easy access to copper since the metal was readily available on the island of Kypros (Cyprus) from which the Latin name for copper, cuprum, is derived.
- Copper sulfate is the key active component of the fungicidal “Bordeaux mixture” that was invented in the 19th century and is still used in agriculture today, as are numerous other copper-based agrochemicals.
- Pathogenic microbes such as bacteria, fungi and viruses are responsible for many of the diseases in multicellular organisms as illustrated by the following non-limiting examples.
- bacterial infections are involved in skin diseases such as acne ( Propionibacterium acnes ) and eczema ( Staphylococcus aureus ).
- Healthcare-acquired infections caused by meticillin-resistant Staphylococcus aureus (MRSA), Acinetobacter sp. Klebsiella pneumonia (in which the NDM-1 enzyme gene was originally identified) and Legionella pneumophila which is the cause of Legionnaire's disease.
- Escherichia coli E. coli
- E. coli is a common cause of urinary tract infections.
- Pathogenic E. coli 0157:117 causes gastroenteritis when ingested through contaminated food.
- fungi Diseases caused by fungi may be relatively mild such as athlete's foot ( Tricophyton sp.), dandruff ( Malassezia globosa ) and thrush ( Candida albicans ), but fungi such as Aspergillus fumigatus ( A. fumigatus ) and Candida albicans ( C. albicans ), and yeasts such as Cryptococcus neoformans may cause life-threatening infections in immune compromised patients. Viruses are also responsible for common diseases such as colds (Rhinoviruses) and influenza (Influenza viruses A. B and C) and cold sores (Herpes simplex virus), to more serious viral diseases such as rabies and ebola.
- Tricophyton sp. Tricophyton sp.
- dandruff Malassezia globosa
- thrush Candida albicans
- yeasts such as Cryptococcus neoformans may cause life-threatening
- Bacterial infections of skin wounds such as pressure sores and diabetic leg ulcers can exacerbate the condition and copper salts and copper-based compositions have been shown to be effective against these diseases by virtue of both their anti-bacterial effects and their ability to stimulate wound healing by enhancing growth factor production.
- copper or copper-zinc compositions have been shown to be effective at, for example, ameliorating the effects of mild to moderate sunburn and mild burns, and also in reducing the itching and inflammation caused by insect bites and reducing the appearance of wrinkles.
- Phytophthora infestans the cause of potato blight, became highly resistant to Metalaxyl in the late 20 th century.
- Pathogenic viruses similarly develop resistance to anti-viral drugs, the development of resistance of the H1N1 “swine flu” influenza A strain to oseltamivir phosphate (TAMIFLU®, a registered trademark of Genentech. San Francisco, Calif. USA) in the past five years being a recent example.
- an antimicrobial composition comprising a solution comprising a copper salt in water; a basic ammonium salt added to the copper salt solution to generate an insoluble copper-ammonium complex; and at least one water soluble acid added to the copper salt solution to solubilize the copper-ammonium complex and to control the pH of the clear blue acid-solubilized copper-ammonium solution thus formed.
- FIG. 1 is a graph depicting the effects of copper sulfate and composition Cu#1 on the growth of bacterial strain S1 ( S. aureus );
- FIG. 2 is a graph depicting the effects of zinc sulfate alone and combined with composition Cu#1 on the growth of bacterial strain S1 ( S. aureus );
- FIG. 3 is a bar chart depicting the effects of gel, zinc sulfate (100 ⁇ g/ml) alone and compositions Cu#9 or Cu#10 (200 ⁇ g/ml) alone and in combination with zinc sulfate on the growth of S1 ( S. aureus );
- FIG. 4 is a graph of human skin cell survival after a 24 hour culture with copper sulfate and compositions Cu#9, Cu#10 and Cu—Zn#1: Gel+Cu#9, Gel+Cu—Zn#1; and
- FIG. 5 is a graph of human skin cell survival after a 24 hour culture with Gel+Cu#9. Gel+Cu—Zn#1, and two CLEARASIL® (a trademark of Reckitt Benckiser LLC of Berkshire, England) anti-acne cream products containing the active compounds salicylic acid and benzoyl peroxide.
- CLEARASIL® a trademark of Reckitt Benckiser LLC of Berkshire, England
- the inventor has surprisingly found that acid-solubilized copper-ammonium and copper-zinc-ammonium complexes described herein are useful in combating specific pathogenic microbes that are antibiotic-resistant in the case of certain bacteria or otherwise difficult to treat or control in the case of certain bacterial and fungal strains. Furthermore, the inventor has surprisingly found that these acid-solubilized copper-ammonium complexes can be highly effective against difficult to treat bacteria, for example, MRSA and Acinetobacter baumannii with simultaneous lack of toxicity to human skin cells in culture at similar concentrations.
- the applications of the acid-solubilized copper-ammonium or copper-zinc-ammonium compositions described herein are primarily for topical use, for example, on the skins or mucous membranes of animals and humans, on the leaves of plants, or, for example, on surfaces in the environment, such as in homes or hospitals.
- Exceptions to topical uses include, for example, (i) the treatment of water contaminated by one or more microbes that could be made potable by the use of an acid-solubilized copper-ammonium or acid-solubilized copper-zinc-ammonium composition to remove or kill microbes, or (ii) making water fit for use by removal or killing of microalgae or bacteria contaminating the water in a structure such as a swimming pool or hot tub by the addition of one or more of the acid-solubilized copper or copper-zinc compositions described herein.
- the acid-solubilized copper-ammonium complex compositions described herein can be applied topically to the skin of a patient for preventing or treating, for example, an MRSA infection or a fungal infection such as C. albicans . They can also be applied topically by spraying, for example, to the leaves of plants with a fungal infection such as powdery mildew. Once on the surface, the disinfecting properties of the copper ion complex can remain effective for a considerable period of time.
- the acid-solubilized copper-ammonium complexes can also be applied to surfaces, for example, either by spraying or by application with a cloth, and unexpectedly can be effective against multiple different pathogenic microbes simultaneously and can provide protection against infection and re-infection with such microbes. Once on the surface, the disinfecting properties of the copper ion complex can remain effective for a considerable time.
- the present acid-solubilized copper-ammonium complexes and substrates impregnated therewith can provide a very effective inhibition of the growth of pathogenic microbes hitherto difficult to treat with conventional drugs and/or conventional disinfectant regimes.
- This inhibition of growth of pathogenic microbes can surprisingly be at concentrations that are not toxic to human skin cells.
- the acid-solubilized copper-ammonium compositions can be made into topical formulations such as creams, gels, spray solutions, irrigation solutions and impregnated dressings which can be for application to skin and mucosal surfaces, leaves of plants, and work surfaces in homes, hospitals, factories, vehicles etc.
- topical formulations such as creams, gels, spray solutions, irrigation solutions and impregnated dressings which can be for application to skin and mucosal surfaces, leaves of plants, and work surfaces in homes, hospitals, factories, vehicles etc.
- the elemental concentration of copper in the compositions is of the order 1 to 10 grams/deciliter preferably 3 to 7 grams/deciliter, more preferably 3.5 to 5 grams/deciliter, with the solvent phase being distilled or deionised water.
- the elemental concentration of copper and zinc in the compositions is of the order 1:1 with the solvent phase being distilled or deionised water.
- antimicrobial preservatives may include, for example, mandelic acid, glycerol, potassium sorbate, phenoxyethanol, sodium benzoate.
- An effective combination is potassium sorbate (KS) and sodium benzoate (NaB).
- KS potassium sorbate
- NaB sodium benzoate
- the Propionibacterium acnes strain ATCC 11828 P. acnes
- composition to be tested was either diluted with distilled water and 5 microliters was placed onto a 5 millimeter filter paper disc or was added to the Aloe vera-based gel (without preservatives) described above at various concentrations and a 5 microliter drop was placed onto the agar surface.
- the plates were then incubated at 37° C. for 24 hours (under anaerobic conditions for P. acnes ), when the zones of inhibition (ZoI) were measured in millimeters) twice at a 900 angle using a ruler and the average diameter (D) was calculated.
- composition Cu#1 alone had an AoI of 3 mm 2 , but this increased to 13, 20 and 28 mm 2 when combined with zinc sulfate at concentrations of 50, 100 and 200 micrograms/milliliter, respectively.
- compositions Cu#9 and Cu#10 200 micrograms/milliliter in gel, alone and combined with zinc sulfate (100 micrograms/milliliter) in gel on the growth of S1 ( S. aureus ).
- the results show that the gel alone and zinc sulfate in gel have no effect on the growth of S1 ( S. aureus ).
- Compositions Cu#9 and Cu#10 in gel alone both inhibited the growth of S1 ( S. aureus ) with AoIs of 20 and 33 mm 2 , respectively.
- compositions Cu#9 and Cu#10 showed increased inhibition of the growth of S1 ( S.
- the acidity of the compositions is responsible for their greater antimicrobial activity when compared to copper sulfate.
- the stock solution of Cu#10 has a higher pH than an equivalent solution of copper sulfate and yet has a greater inhibitory effect on the growth of P. acnes .
- composition Cu—Zn#1 was one of the more inhibitory compositions despite having only 37.5% of the elemental copper of the Cu# compositions, but in conjunction with an equimolar concentration of elemental zinc (1.5 grams/deciliter in the stock solution).
- the impressive activity of Cu—Zn#1 supports the conclusions from the results presented in FIGS. 2 and 3 , that there is synergy between copper and zinc ions and shows that this acid-solubilized copper-zinc-ammonium complex demonstrates a greater than expected inhibitory effect against P. acnes .
- composition Cu—Zn#1 may have therapeutic value in the treatment of acne, a disease strongly associated with P. acnes .
- P. acnes since it is known that P.
- the acid-solubilized copper-zinc-ammonium complex Cu—Zn#1 may be of therapeutic value in the treatment of acne since it strongly inhibits the growth of P. acnes and the pH values of a 1% (vol/vol) formulation of Cu—Zn#1 in the gel with preservatives is around pH 4.6.
- the aerobic bacterial strains Acinetobacter baumannii ( A. baumannii ), methicillin-resistant Staphylococcus aureus (MRSA) and Klebsiella pneumonia ( K. pneumoniae ) were isolated from swabs taken in a hospital ward.
- Escherichia coli (NCTC 9001; E. coli ) is a clinical isolate from a patient's urinary bladder; all strains were cultured in RPMI-1640.
- Stock solutions of the compounds/compositions to be tested were diluted so that double dilutions in the microplate assays commenced at a 1% vol/vol concentration. Double dilutions of the compositions to be tested were prepared in RPMI-1640 in a 96-well tissue culture plate.
- the bacterial cultures were diluted 1:40 with fresh RPMI and added to the compositions.
- P. acnes was cultured as described in EXAMPLE 1 (Agar plate test methods) and a sample was diluted 1:100 with fresh BHI. Double dilutions of the compositions to be tested were prepared as described above in distilled water in a 96-well tissue culture plate (100 microliters) and 100 microliters of the diluted P. acnes culture was added. The plates were then incubated at 37° C. for 24 hours (under anaerobic conditions for P. acnes ). The minimum inhibitory concentration (MIC) of the compositions was defined as the lowest concentration at which no visible bacterial growth was observed.
- MIC minimum inhibitory concentration
- Table 4 shows the MIC results for copper sulfate, zinc sulfate and various compositions described in Tables 1 and 2.
- the two copper-based compositions tested (Cu#3 and Cu#9) were twice as active as copper sulfate.
- zinc sulfate had a lower MIC with P. acnes than any of the Cu-based products and the acid-solubilized copper-zinc-ammonium formulation
- Cu—Zn#1 was the most active composition tested.
- Cu—Zn#3 which has the same amount of elemental copper as Cu—Zn#1 but 6-fold less elemental zinc (see Table 2) was 4-fold less active than Cu—Zn#1.
- Table 5 shows the MIC results for Cu—Zn compositions #1 to #5 which have varying ratios of elemental copper and zinc, whilst the amounts of ammonium carbonate used to make the Cu—Zn complexes and the amount of hydrochloric acid used to solubilize the Cu—Zn complexes remained constant (see Table 2).
- composition Cu—Zn#1 was 4-fold more active against the growth of P. acnes than Cu—Zn#3 and in this experiment Cu—Zn#2.
- Cu—Zn#4 and #5 were both equally half as active as Cu—Zn#2 and #3 and 8-fold less active than Cu—Zn#1. These results show that composition Cu—Zn#1 comprising equimolar elemental copper and zinc is the most active composition against the growth of P. acnes of all those tested. The results with Cu—Zn#2 and #3 suggest that the role of copper against the growth of P. acnes is somewhat greater than that of zinc, but the surprising synergy of the two metals together when in equimolar equivalence (Cu—Zn#1) creates by far the most effective composition against the growth of P. acnes .
- A. baumannii are both clearly more sensitive to the effects of the copper sulfate, Cu# and Cu—Zn# compositions than E. coli and K. pneumonia , with A. baumannii being surprisingly sensitive to the inhibitory effect of the Cu—Zn# compositions. Since A. baumannii is a particularly persistent bacterium that causes healthcare acquired infections (HAIs), cleaning and/or fogging with composition Cu—Zn#1 may be particularly useful in freeing hospitals and other healthcare facilities from this increasingly prevalent and difficult to treat microbe.
- HAIs healthcare acquired infections
- MRSA and E. coli were both more sensitive to the growth inhibitory effects of the Cu# compositions than the Cu—Zn# compositions and copper sulfate, whilst the opposite was true for A. baumannii and K. pneumoniae .
- E. coli was generally around 8-fold less sensitive to all of the compositions tested than MRSA.
- Three compositions were made using ammonium hydroxide see Table 1 for details) and tested against MRSA, A. baumannii and E. coli as shown at the bottom of Table 6.
- Cu#3 is a stable composition and Cu#3a was equally as stable and active against the three bacterial strains tested.
- Cu10a showed similar activity to Cu#10 and Cu#11a with citric acid was as active as the other Cu# compositions. Not only are these (and other compositions prepared with ammonium hydroxide—see below) compositions more stable, they are quicker and easier to make because no carbon dioxide is liberated, and the Cu—/Cu—Zn-ammonium complexes formed with ammonium hydroxide require less acid for solubilization, so the pH of the compositions can be higher, representing advantages in formulations thereof.
- MRSA is perhaps the best known and most problematic pathogenic bacterium causing HAIs, but the USA300 MRSA strain has also become an increasing concern in community-associated infections particularly of the skin.
- Carbapenem-resistant K. pneumoniae Carbapenem-resistant K. pneumoniae (CRKP) has emerged over the past 10 years to become a worldwide nosocomial pathogen that is almost totally drug-resistant.
- CNKP Carbapenem-resistant K. pneumoniae
- Cu# and Cu—Zn# compositions Table 6 suggests that these compositions may be useful for cleaning, fogging and the like in hospitals, homes and other buildings to remove these organisms.
- Cu#3 may be a particularly effective composition for cleaning and disinfection to remove these pathogenic microbes from buildings.
- A-431 (ATCC) was cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum and 2 mM L-glutamine (complete medium) in a humidified incubator at 37′C with a 5% CO 2 in air atmosphere.
- the cells were trypsinized, washed, counted and 2 ⁇ 10 4 cells were plated into the wells of flat-bottom 96-well plates in complete medium and cultured for 3 days until a confluent monolayer was formed.
- the products tested were: (i) Copper sulfate, Cu#9, Cu#10 and Cu—Zn#1 as shown in FIG.
- SRB sulforhodamine B
- the cells were washed twice with RPMI-1640 medium and then fixed with 10% trichloroacetic acid for 1 hour at 4° C. After washing twice with tap water, the cells were stained with SRB (0.4% w/v SRB in 1% acetic acid) for 30 min at room temperature. After washing twice with tap water the remaining stain was dissolved in 10 mM Tris base and the absorbance of the wells was measured on a Dynatech Multiplate ELISA reader at 540 nm. Percent cell survival was calculated by dividing the test product absorbance by control absorbance and multiplying by 100.
- FIG. 4 shows that copper sulfate and compositions Cu#9 and #10 had almost identical cytotoxicity profiles with human skin cells with 50% cytotoxic concentrations (CC 50 ) of 50 micrograms/milliliter, suggesting that copper ions are responsible for the cytotoxic effects of the three products.
- compositions described herein such as Cu#3, #3a, #9, #10, #10a, #11a, #12, #13 and Cu—Zn#1 and #3 can inhibit the growth of bacteria such as MRSA and A. baumannii at concentrations (MIC 1.6-6.3 microgram/milliliter—see Table 6) well below those that cause cytotoxicity to human skin cells in culture (around 30 micrograms/milliliter).
- FIG. 5 shows the effects of gel containing 1% vol/vol of compositions Cu#9 (400 micrograms/milliliter elemental copper) and Cu—Zn#1 (150 micrograms/liter elemental copper and zinc) and two commercially available CLEARASIL® (a registered trademark of Reckitt Benckiser LLC of Berkshire England) acne creams on the survival of human skin cells in tissue culture.
- CLEARASIL® a registered trademark of Reckitt Benckiser LLC of Berkshire England
- Chalara fraxinea isolate 196/28 C. fraxinea
- Aspergillus niger A. niger
- Pm powdery mildew
- 10 microliters of the test compositions diluted in sterile distilled water were placed in the wells of a 12-well tissue culture plate and 1 milliliter of PDA was added by pipette to each well. The plate was agitated to evenly distribute the test composition evenly through the agar (distilled water alone was used as control) and then the agar was allowed to set.
- Plugs of agar containing fungal hyphae (3 mm 2 ) from an established fungal culture were carefully cut out using a scalpel and inserted into holes in the centre of the agar in each well of the 12-well plate which was then cultured at room temperature (around 22° C.). Since the rate of fungal growth varies depending on the strain, the experiments were assessed after 3 days for Pm, and at appropriate intervals of 3-4 days for A. niger and around 7 days for C. fraxinea . To assess the effects of compositions on fungal growth, the diameter of the fungal hyphae was measured twice at a 90° angle using a ruler and the average diameter in millimeters was calculated. If no fungal growth could be detected by eye, the cultures were observed by phase microscopy (40 ⁇ ) to confirm that there was no growth (NG) as judged by visual examination.
- phase microscopy 40 ⁇
- Table 7 shows the effects of copper sulfate and composition Cu#16 on the growth of C. fraxinea .
- Composition Cu#16 strongly inhibited fungal growth at a concentration of 125 micrograms/milliliter at both time points and was around 30-times more inhibitory to fungal growth than copper sulfate (results with 3.75 micrograms/milliliter Cu#16 were very similar to those with 125 micrograms/milliliter of copper sulfate), presumably owing to the solubilization of the copper-ammonium complex in Cu#16 with phosphorous acid (see Table 1), which is known to have anti-fungal activity.
- composition Cu—Zn#1 is less effective than composition Cu—Zn#7 at inhibiting the growth of C. fraxinea and although the formulations of the two compositions are very similar (Table 2), composition Cu—Zn#7 contains phosphorous acid as the copper-zinc solubilizing acid whereas Cu—Zn#1 contains hydrochloric acid. Phosphorous acid is known to have anti-fungal activity and its use in composition Cu—Zn#7 results in an anti-fungal composition that is 3- to 10-fold more active than Cu—Zn#1 on days 7 and 14 of the assay, respectively.
- a 1% concentration of Cu—Zn#7 contains 150 micrograms/milliliter of elemental copper, so comparing the effects of Cu—Zn#7 to those of copper sulfate and Cu#16 in Table 7 indicates that Cu—Zn#7 is a slightly less effective inhibitor of C. fraxinea growth than Cu#16, but it is considerably more effective than copper sulfate.
- compositions Cu—Zn#1 and Cu—Zn#7 on the growth of C. fraxinea on PDA.
- the Cu—Zn# compositions were used as a percent dilution of the stock solutions (Table 2), so a 1% solution contains 150 ⁇ g/ml of elemental copper (and zinc).
- Diameter of fungal growth (mm) Day 7 Day 14 Cu—Zn#1 (%) 1 7 18 0.3 16 20* 0.1 16 20 0.03 16 20 0.01 16 20 Cu—Zn#7 (%) 1 4 8 0.3 8 14 0.1 15 17 0.03 16 19 0.1 16 20
- Control 16 20 *20 millimeters is the width of the wells and represents confluent fungal growth. 3.
- Table 9 shows the effects of copper sulfate and composition Cu#16 on the growth of A. niger .
- Composition Cu#16 completely inhibited fungal growth at a concentration of 125 micrograms/milliliter and at all three time points was 3- to 10-fold more inhibitory to fungal growth than copper sulfate as was seen with C. fraxinea (Table 7).
- composition Cu#16 was made with ammonium hydrogen carbonate whilst Cu#27 contains ammonium hydroxide and as shown before (Table 6), this made no significant difference to the anti-fungal activity of the composition.
- precipitation was noted in composition Cu#16 after a few days at room temperature whilst this was not seen with Cu#27, suggesting that ammonium hydroxide may be surprisingly advantageous in the preparation of copper-ammonium complexes when phosphorous acid is used to solubilize the complex.
- compositions Cu—Zn#7 and Cu—Zn#10 which were equally effective inhibitors of Pm growth, differed in the use of ammonium carbonate and ammonium hydroxide, respectively, to create the Cu—Zn-ammonium complexes which were solubilized with phosphorous acid in each case (Table 2).
- ammonium carbonate was used to prepare Cu—Zn-ammonium complexes that were solubilized with phosphorous acid.
- the Cu—Zn# compositions were more effective inhibitors of Pm growth than the Cu# compositions in terms of elemental copper content.
- the Cu—Zn# compositions completely inhibited growth as did the Cu# compositions—but at 375 micrograms/milliliter of elemental copper.
- the Cu—Zn# compositions still strongly inhibited Pm growth, whilst at 37.5 micrograms/milliliter the Cu# compositions were only slightly inhibitory to Pm growth. Calculations indicate that the concentration required to inhibit the growth of Pm by 50% was around 40 micrograms/milliliter for the Cu—Zn# compositions and around 170 micrograms/milliliter for the Cu# compositions.
- C. fraxinea is the cause of ash tree die-back which is a serious forestry problem in Europe.
- A. niger causes black mold on certain fruits and vegetables such as grapes, onions, and peanuts, and is a common contaminant of food.
- Fungi of the Genus Blumeria are widespread plant pathogens that cause powdery mildew on the leaves of many plants including grapevines, Curcubits, onions, apple and pear trees.
- the results described above show that copper-ammonium and copper-zinc-ammonium complexes solubilized with phosphorous acid are highly effective at inhibiting the growth of the various plant pathogenic fungi tested and therefore may have practical applications in the agricultural field for protecting of crops, plants, trees, flowers and ornamental shrubs.
- Cu—Zn#7 and #10 were significantly more effective than Cu#16 and #27 at inhibiting the growth of Powdery mildew suggesting these compositions may have advantageous anti-fungal activity against certain plant pathogens.
- Candida albicans C. albicans
- 1-1, 3-1 and 4-1 were isolated from human blood, vagina and oropharynx, respectively.
- Cryptococcus neoformans ( C. neoformans ) strain CCTP13 was used. All strains were cultured in RPMI-1640 medium at 37° C.
- the copper sulfate and Cu# compositions started at a high concentration of 200 micrograms/milliliter, whilst the Cu—Zn# compositions started at a high concentrations of 1% of the stock solution (Table 2) and zinc sulfate and phosphorous acid started with a high concentrations equivalent to those in Cu—Zn#7 and #10 (see the legend of Table 1 for details) doubling dilutions (100 microliters) of the compositions were prepared in RPMI-1640 in a 96-well tissue culture plate. Overnight C. albicans and C. neoformans cultures were diluted 1:40 and 1:10 respectively with fresh RPMI containing 40 mM MOPS buffer and 90 microliters was added to the compositions in the plate.
- Resazurin A (10 microliters of a 0.0675% wt/vol solution in distilled water) was added as an indicator of growth, and the cultures were incubated at 37° C. for 24 hr.
- the minimum inhibitory concentration (MIC) of the compounds/compositions was defined as the lowest concentration at which the resazurin A indicator remained blue (living cells convert the blue dye to a pink color).
- Table 11 shows that all of the strains tested were surprisingly sensitive to copper, with MICs similar to those seen with MRSA and A. baumannii (around 6 micrograms/milliliter; Table 6), whether in the form of copper sulfate or the acid-solubilized copper-ammonium compositions (Cu#).
- the yeast C. neoformans was also highly sensitive to copper regardless of the form, but was less sensitive to Cu—Zn#1 than the C. albicans strains.
- the growth of the C. albicans strains was not affected by zinc sulfate or phosphorous acid (MIC>150 and >500 micrograms/milliliter, respectively).
- the growth of C. neoformans was also unaffected by zinc sulfate.
- C. neoformans was also very sensitive to copper sulfate and the Cu# compositions, but was much less sensitive to Cu—Zn#1 and zinc sulfate. C. neoformans causes severe meningitis in people with HIV/AIDS and selective delivery of a copper-containing complex to the brain may be a potential therapy for this lethal disease.
- Samples (3 milliliters) of composition Cu#1 and Aloe vera gel with preservatives containing 1% vol/vol of composition Cu#1 were placed in 7 milliliter sterile plastic tubes and replicate samples were stored under four conditions; at 37° C. in a humidified incubator, at room temperature (around 22° C.) in a cupboard, at 4° C. in a cold room, and at ⁇ 20° C. in a freezer. After 5 months of storage, a set of samples of Cu#1 and the gel containing 1% Cu#1 were allowed to come to room temperature.
- the gel samples (5 microliters) and the samples of Cu#1 (diluted 1:1 or 1:10 vol/vol in distilled water and 5 microliters placed on a paper disc) were tested against bacterial strain S1 ( S. aureus ) in the agar plate test, and after 24 hour culture at 37° C., the diameters of the zones of inhibition were measured as described in EXAMPLE 1.
- Table 12 shows the zones of inhibition for the samples of composition Cu#1 stored at various temperatures for 5 months.
- the sample stored at 37° C. was slightly more inhibitory to the growth of S1 ( S. aureus ) than the other samples which gave very similar zones of inhibition at both concentrations tested.
Priority Applications (31)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/106,676 US9474282B2 (en) | 2013-12-13 | 2013-12-13 | Acid-solubilized copper-ammonium complexes and copper-zinc-ammonium complexes, compositions, preparations, methods, and uses |
CN201480072256.1A CN105873442B (zh) | 2013-12-13 | 2014-12-12 | 酸溶性铜-铵络合物和铜-锌-铵络合物、组合物、制备、方法和用途 |
DK14869541.4T DK3079476T3 (da) | 2013-12-13 | 2014-12-12 | Syreopløselige kobber-ammonium-komplekser og kobber-zink-ammonium-komplekser, sammensætninger, præparat, metoder og anvendelse |
BR112016013486A BR112016013486A2 (pt) | 2013-12-13 | 2014-12-12 | Composição antimicrobiana, e, método de produção de uma composição antimicrobiana |
EP14869541.4A EP3079476B1 (en) | 2013-12-13 | 2014-12-12 | Acid-solubilized copper-zinc-ammonium complexes, compositions, preparations, methods, and uses |
PL14869541.4T PL3079476T3 (pl) | 2013-12-13 | 2014-12-12 | Rozpuszczane w kwasie kompleksy miedziowo-cynkowo-amonowe, kompozycje, preparaty, sposoby i zastosowania |
PCT/US2014/069908 WO2015089358A1 (en) | 2013-12-13 | 2014-12-12 | Acid-solubilized copper-ammonium complexes and copper-zinc-ammonium complexes, compositions, preparations, methods, and uses |
CA2933594A CA2933594C (en) | 2013-12-13 | 2014-12-12 | Acid-solubilized copper-ammonium complexes and copper-zinc-ammonium complexes, compositions, preparations, methods, and uses |
PE2016000798A PE20161172A1 (es) | 2013-12-13 | 2014-12-12 | Complejos de cobre-amonio y de cobre-zinc-amonio solubilizados con acidos, composiciones, preparaciones, metodos y usos |
CR20160317A CR20160317A (es) | 2013-12-13 | 2014-12-12 | Complejos de cobre-amonio y de cobre-zinc-amonio solubilizados con ácidos, composiciones, preparaciones, métodos y usus |
US15/103,872 US10729139B2 (en) | 2013-12-13 | 2014-12-12 | Acid-solubilized copper-ammonium complexes and copper-zinc ammonium complexes, compositions, preparations, methods, and uses |
PT148695414T PT3079476T (pt) | 2013-12-13 | 2014-12-12 | Complexos de cobre-zinco-amónio solubilizados em ácido, composições, preparações, métodos e utilizações |
HRP20221027TT HRP20221027T1 (hr) | 2013-12-13 | 2014-12-12 | Kompleksi bakar-cink-amonijak solubilizirani u kiselini, sastavi, pripravci, postupci i primjene |
HUE14869541A HUE059877T2 (hu) | 2013-12-13 | 2014-12-12 | Savval oldott réz-cink-ammónium komplexek, kompozíciók, preparárumok, módszerek és felhasználások |
AU2014362252A AU2014362252B2 (en) | 2013-12-13 | 2014-12-12 | Acid-solubilized copper-ammonium complexes and copper-zinc-ammonium complexes, compositions, preparations, methods, and uses |
EA201691090A EA201691090A1 (ru) | 2013-12-13 | 2014-12-12 | Растворимые в кислотах медь-аммонийные комплексы и медь-цинк-аммонийные комплексы, композиции, получения, способы и применения |
ES14869541T ES2925740T3 (es) | 2013-12-13 | 2014-12-12 | Complejos de cobre-zinc-amonio solubilizados en ácido, composiciones, preparaciones, métodos y usos |
KR1020167018273A KR102061823B1 (ko) | 2013-12-13 | 2014-12-12 | 산-가용화된 구리-암모늄 착체 및 구리-아연-암모늄 착체, 조성물, 제제, 방법 및 용도 |
LTEPPCT/US2014/069908T LT3079476T (lt) | 2013-12-13 | 2014-12-12 | Rūgštyje soliubilizuoti vario-cinko-amonio kompleksai, kompozicijos, paruošimo būdai, metodai ir naudojimo būdai |
AP2016009265A AP2016009265A0 (en) | 2013-12-13 | 2014-12-12 | Acid-solubilized copper-ammonium complexes and copper-zinc-ammonium complexes, compositions, preparations, methods, and uses |
RS20220718A RS63448B1 (sr) | 2013-12-13 | 2014-12-12 | Bakar-cink-amonijum kompleksi solubilizovani u kiselini, kompozicije, preparati, postupci i upotrebe |
EP22176603.3A EP4074318A1 (en) | 2013-12-13 | 2014-12-12 | Acid-solubilized copper-ammonium complexes and copper-zinc-ammonium complexes, compositions, preparations, methods, and uses |
TN2016000237A TN2016000237A1 (en) | 2013-12-13 | 2014-12-12 | Acid-solubilized copper-ammonium complexes and copper-zinc-ammonium complexes, compositions, preparations, methods, and uses. |
MX2016007640A MX2016007640A (es) | 2013-12-13 | 2014-12-12 | Complejos de cobre-amonio y de cobre-zinc-amonio solubilizados con acidos, composiciones, preparaciones, metodos y usos. |
JP2016539109A JP6808489B2 (ja) | 2013-12-13 | 2014-12-12 | 酸可溶性銅−アンモニウム錯体および銅−亜鉛−アンモニウム錯体、組成物、調製、方法、ならびに使用 |
PH12016501103A PH12016501103A1 (en) | 2013-12-13 | 2016-06-09 | Acid-solubilized copper-ammonium complexes and copper-zinc-ammonium complexes, compositions, preparations, methods, and uses |
IL246143A IL246143A0 (en) | 2013-12-13 | 2016-06-09 | Copper-ammonium complexes and acid-soluble copper-zinc-ammonium complexes, preparations, preparation, methods and uses |
DO2016000134A DOP2016000134A (es) | 2013-12-13 | 2016-06-10 | Complejos de cobre-amonio y de cobre-zinc-amonio solubilizados con ácidos, composiciones, preparaciones, métodos y usos. |
NI201600080A NI201600080A (es) | 2013-12-13 | 2016-06-10 | Complejos de cobre-amonio y de cobre-zinc-amonio solubilizados con ácidos, composiciones, preparaciones, métodos y usos. |
MA39179A MA39179A1 (fr) | 2013-12-13 | 2016-07-11 | Complexes de cuivre-ammonium et complexes de cuivre-zinc-ammonium solubilisés en milieu acide, compositions, préparations, procédés et utilisations |
JP2020162853A JP7089562B2 (ja) | 2013-12-13 | 2020-09-29 | 酸可溶性銅-アンモニウム錯体および銅-亜鉛-アンモニウム錯体、組成物、調製、方法、ならびに使用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/106,676 US9474282B2 (en) | 2013-12-13 | 2013-12-13 | Acid-solubilized copper-ammonium complexes and copper-zinc-ammonium complexes, compositions, preparations, methods, and uses |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/103,872 Continuation US10729139B2 (en) | 2013-12-13 | 2014-12-12 | Acid-solubilized copper-ammonium complexes and copper-zinc ammonium complexes, compositions, preparations, methods, and uses |
Publications (2)
Publication Number | Publication Date |
---|---|
US20150164085A1 US20150164085A1 (en) | 2015-06-18 |
US9474282B2 true US9474282B2 (en) | 2016-10-25 |
Family
ID=53366866
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/106,676 Active 2034-04-06 US9474282B2 (en) | 2013-12-13 | 2013-12-13 | Acid-solubilized copper-ammonium complexes and copper-zinc-ammonium complexes, compositions, preparations, methods, and uses |
US15/103,872 Active US10729139B2 (en) | 2013-12-13 | 2014-12-12 | Acid-solubilized copper-ammonium complexes and copper-zinc ammonium complexes, compositions, preparations, methods, and uses |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/103,872 Active US10729139B2 (en) | 2013-12-13 | 2014-12-12 | Acid-solubilized copper-ammonium complexes and copper-zinc ammonium complexes, compositions, preparations, methods, and uses |
Country Status (28)
Country | Link |
---|---|
US (2) | US9474282B2 (pt) |
EP (2) | EP4074318A1 (pt) |
JP (2) | JP6808489B2 (pt) |
KR (1) | KR102061823B1 (pt) |
CN (1) | CN105873442B (pt) |
AP (1) | AP2016009265A0 (pt) |
AU (1) | AU2014362252B2 (pt) |
BR (1) | BR112016013486A2 (pt) |
CA (1) | CA2933594C (pt) |
CR (1) | CR20160317A (pt) |
DK (1) | DK3079476T3 (pt) |
DO (1) | DOP2016000134A (pt) |
EA (1) | EA201691090A1 (pt) |
ES (1) | ES2925740T3 (pt) |
HR (1) | HRP20221027T1 (pt) |
HU (1) | HUE059877T2 (pt) |
IL (1) | IL246143A0 (pt) |
LT (1) | LT3079476T (pt) |
MA (1) | MA39179A1 (pt) |
MX (1) | MX2016007640A (pt) |
NI (1) | NI201600080A (pt) |
PE (1) | PE20161172A1 (pt) |
PH (1) | PH12016501103A1 (pt) |
PL (1) | PL3079476T3 (pt) |
PT (1) | PT3079476T (pt) |
RS (1) | RS63448B1 (pt) |
TN (1) | TN2016000237A1 (pt) |
WO (1) | WO2015089358A1 (pt) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160309722A1 (en) * | 2013-12-13 | 2016-10-27 | Myco Sciences Limited | Acid-solubilized copper-ammonium complexes and copper-zinc ammonium complexes, compositions, preparations, methods, and uses |
WO2019079912A1 (es) * | 2017-10-25 | 2019-05-02 | Compañia Minera San Geronimo | Método para el control de hongos y bacterias en osamentas y anatomía patológica; método para la desinfección y sanitización de ambientes y/o superficies contaminados; y usos |
US11395492B2 (en) | 2015-06-08 | 2022-07-26 | Vm Agritech Limited | Antimicrobial and agrochemical compositions |
US11596705B2 (en) * | 2017-10-27 | 2023-03-07 | Onelife S.A. | Kit for detecting residual contaminations on medical devices |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150342195A1 (en) * | 2014-06-03 | 2015-12-03 | Myco Sciences Limited | Anti-microbial compositions, preparations, methods, and uses |
CL2016002960A1 (es) * | 2016-11-18 | 2017-01-27 | Univ Chile | Formulación hibrida metal/estructura de carbono con aplicaciones dentales en el tratamiento de la hipersensibilidad dentinaria, desmineralización, y la caries |
MX2020000827A (es) * | 2017-07-26 | 2020-10-05 | Nutriag Ltd | Acido de fosforo y composiciones componentes de cobre estabilizadas con alquilamina o alcanolamina para controlar una enfermedad de las plantas causada por un organismo fitopatogenico. |
GB2595304A (en) * | 2020-05-22 | 2021-11-24 | Copper Clothing Ltd | Antimicrobial material |
Citations (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1988752A (en) | 1931-10-03 | 1935-01-22 | Stanco Inc | Copper fungicide |
US2414660A (en) | 1942-06-27 | 1947-01-21 | Tennessee Copper Company | Copper fungicides and process of producing same |
US4048324A (en) | 1973-12-28 | 1977-09-13 | Armand Kohn | Fungicidal composition and method |
EP0136137A2 (en) * | 1983-09-16 | 1985-04-03 | BP Chemicals Limited | Fungicidal compositions |
JPH01305013A (ja) | 1988-06-03 | 1989-12-08 | Shinagawa Nenryo Kk | 化粧料用防腐剤 |
US4952398A (en) | 1988-03-17 | 1990-08-28 | Jean Tapin | Biocidal composition with copper algicide |
US5373025A (en) | 1992-02-24 | 1994-12-13 | Olin Corporation | Sanitizer for swimming pools, spas, and hot tubs |
US6168643B1 (en) * | 1997-01-23 | 2001-01-02 | Safergro Laboratories, Inc. | Inorganic phosphorus fertilizer |
US6340384B1 (en) | 1999-05-24 | 2002-01-22 | Lonza Inc. | Copper/amine oxide wood preservatives |
US20040001791A1 (en) * | 2000-11-16 | 2004-01-01 | Zeiler Kenneth T. | Composition, method of use, and devices for the treatment of onychomycosis |
US6896908B2 (en) | 2001-01-30 | 2005-05-24 | U.S. Borax Inc. | Wood preservative concentrate |
US6942878B2 (en) | 2000-09-11 | 2005-09-13 | Showa Denko K.K. | Cosmetic composition |
US20060089342A1 (en) | 2000-06-22 | 2006-04-27 | Gavin David F | Topical anti-microbial compositions |
US7060302B1 (en) | 1999-08-31 | 2006-06-13 | Remedy Research Limited | Metal-containing compositions, preparations and uses |
US20070275101A1 (en) | 2006-02-23 | 2007-11-29 | Lu Helen S | Removable antimicrobial coating compositions and methods of use |
US20080004177A1 (en) | 2003-10-17 | 2008-01-03 | Thomas Pfeiffer | Novel Copper-Containing Formulations |
US20090226494A1 (en) | 2005-11-17 | 2009-09-10 | Stephen Spaulding Hickok | Pathogen - controlling products |
US20100015245A1 (en) | 2008-04-24 | 2010-01-21 | Joe Harrison | Combination of Copper Cations with Peroxides or Quaternary Ammonium Compounds for the Treatment of Biofilms |
US8012511B1 (en) | 2005-12-02 | 2011-09-06 | Contact Marketing Solutions, Llc | Acidic composition of matter for use to destroy microorganisms |
US8067403B2 (en) | 2005-12-12 | 2011-11-29 | Allaccem, Inc. | Methods and systems for preparing an antimicrobial composition |
US20120021911A1 (en) | 2009-03-06 | 2012-01-26 | Gowan Co. | Plant Treatment Compositions and Methods for Their Use |
US8273791B2 (en) | 2008-01-04 | 2012-09-25 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially décolletage |
US8287893B2 (en) | 2007-05-18 | 2012-10-16 | Sciessent Llc | Bioactive agrichemical compositions and use thereof |
US8293282B2 (en) | 2008-02-12 | 2012-10-23 | Arch Wood Protection, Inc. | Micronized copper-containing compositions useful to mitigate residues on wood surfaces |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2540209A (en) | 1948-02-18 | 1951-02-06 | Tennessee Copper Company | Copper fungicidal compositions safened with zinc sulfite |
GB1119058A (en) | 1964-07-17 | 1968-07-03 | Allergan Pharma | A stabilized ascorbic acid microbiocidal composition |
FR1544172A (fr) | 1967-09-20 | 1968-10-31 | British Petroleum Co | Produits pesticides, huileux et émulsionnables, à usage agricole et industriel |
TR19072A (tr) | 1973-11-26 | 1978-05-01 | Pepro | Fosforlu tuerevler ihtiva eden fungisid terkipler |
GB1574939A (en) * | 1977-05-12 | 1980-09-10 | Cuprinol Ltd | Compositions containing preservative metals and their use for the preservation of wood and like materials and as fungicides |
DE2807293A1 (de) | 1978-02-21 | 1979-08-23 | Bp Chem Int Ltd | Homogenes, fluessiges, einen cuprammonium-komplex umfassendes praeparat |
CA1117007A (en) * | 1978-06-06 | 1982-01-26 | Bp Chemicals Limited | Fungicidal compositions of low phytotoxicity containing cuprammonium carboxylates and metal carboxylates |
GR75196B (pt) | 1980-05-03 | 1984-07-13 | Basf Ag | |
DE3017123A1 (de) * | 1980-05-03 | 1981-11-05 | Basf Ag, 6700 Ludwigshafen | Fungizid |
HU184319B (en) | 1980-08-27 | 1984-08-28 | Borsodi Vegyi Komb | Fungicide compositions salts of phosphonoic acid-monoesters and process for producing the active agents |
US4544666A (en) | 1983-04-22 | 1985-10-01 | Phyton/Ag, Inc. | Chemotherapeutic agents for the control of plant diseases |
CA1219040A (en) | 1983-05-05 | 1987-03-10 | Elliot V. Plotkin | Measurement of enzyme-catalysed reactions |
JPS6079679A (ja) | 1983-09-29 | 1985-05-07 | フオ−ド モ−タ− カンパニ− | 再充電可能な二酸化マンガン/亜鉛電池 |
ZA852282B (en) * | 1984-04-04 | 1985-11-27 | Osmose Wood Preserv Co America | Preservative composition for wood |
US4622248A (en) * | 1984-04-04 | 1986-11-11 | Osmose Wood Preserving Co. Of America, Inc. | Preservative composition for wood |
DK0518976T3 (da) | 1990-03-06 | 1996-10-14 | David Tate | Fungicide sammensætninger til anvendelse på planter |
JP2988790B2 (ja) * | 1992-08-31 | 1999-12-13 | 触媒化成工業株式会社 | 抗菌剤 |
CN1076080A (zh) | 1993-01-11 | 1993-09-15 | 福州市农业科学研究所植物激素厂 | 70%络氨铜锌可湿性杀菌杀螨和促进植物生长复合粉剂及其制法 |
US5736164A (en) | 1996-08-30 | 1998-04-07 | Taylor; John B. | Fungicidal compositions for plants containing phosphonate and phosphate salts, and derivatives thereof |
US20020193351A1 (en) | 1996-08-30 | 2002-12-19 | Taylor John B. | Fungicidal and bactericidal compositions for plants containing phosphonate and phosphate salts, metal chelates, and derivatives thereof |
JPH10273875A (ja) * | 1997-03-28 | 1998-10-13 | Kohjin Co Ltd | 抗菌防臭ならびに消臭性能を有する組成物 |
US7455851B1 (en) | 1999-06-25 | 2008-11-25 | Arch Chemicals, Inc. | Pyrithione biocides enhanced by silver, copper, or zinc ions |
KR20030069803A (ko) | 2001-01-29 | 2003-08-27 | 애그리케어 리미티드 | 식물 병원체를 제어하기 위한 방법 및 조성물 |
GB0112939D0 (en) | 2001-05-29 | 2001-07-18 | Mini Agriculture & Fisheries | Anti-microbials |
ITMI20022516A1 (it) | 2002-11-27 | 2004-05-28 | Isagro Spa | Composizioni fungicide. |
US20040258838A1 (en) | 2003-06-17 | 2004-12-23 | Richardson H. Wayne | Method for preserving wood materials using precipitated copper compounds |
US8491812B2 (en) * | 2003-12-16 | 2013-07-23 | David J. Moore | Compositions for cleaning contained bodies of water with metal hydrates |
US20080166424A1 (en) | 2004-02-26 | 2008-07-10 | Mixon Stephen P | Compositions and methods for treatment of diseases of the foot of an animal |
ITMI20051019A1 (it) | 2005-05-31 | 2006-12-01 | Isagro Spa | Composizioni fungicide sinergiche |
ITMI20051558A1 (it) | 2005-08-09 | 2007-02-10 | Isagro Spa | Miscele e-o composizioni sinergiche cin elevata attivita'fungicida |
WO2007045256A1 (fr) | 2005-10-17 | 2007-04-26 | Pierre Hirsbrunner | Composition comprenant un alkylsiliconate hydrophobant contenant au moins un indicateur |
GB0523427D0 (en) * | 2005-11-17 | 2005-12-28 | Remedy Res Ltd | Pathogen - controlling products |
CN1826899A (zh) | 2006-02-28 | 2006-09-06 | 赵金华 | 亚磷酸二氢钾在制备杀菌叶面肥中的应用 |
US8221796B2 (en) | 2006-04-25 | 2012-07-17 | Albaugh, Inc. | Copper-based fungicide/bactericide |
JP5101836B2 (ja) | 2006-05-10 | 2012-12-19 | 幸一 島田 | 農薬、抗糸状菌薬剤、及び作物の栽培方法 |
GB0618711D0 (en) | 2006-09-22 | 2006-11-01 | Univ Exeter | Agricultural treatment |
JP4993449B2 (ja) | 2006-10-10 | 2012-08-08 | 日揮触媒化成株式会社 | 抗菌剤 |
WO2009055799A2 (en) | 2007-10-25 | 2009-04-30 | Kenneke Eli L | Compositions and methods for treatment of diseases of the foot of an animal |
CN100579375C (zh) | 2007-11-22 | 2010-01-13 | 浙江林学院 | 一种络氨铜农用杀菌剂生产方法及其产品的用途 |
US20110052720A1 (en) | 2007-12-20 | 2011-03-03 | Wim Van Der Krieken | Compositions for the control of plant pathogens and for use as plant fertilizer |
US20110236504A1 (en) | 2008-05-01 | 2011-09-29 | Panacea Disinfectant Co. Limited | Versatile disinfectant |
TWI489942B (zh) | 2008-12-19 | 2015-07-01 | Bayer Cropscience Ag | 活性化合物組合物 |
DE102011009678A1 (de) | 2011-01-28 | 2012-08-02 | Kurt Obermeier Gmbh & Co. Kg | Holzbehandlungsmittel und Verfahren zum Behandeln von Holz, Holzwerkstoffen oder dergleichen |
JP5927025B2 (ja) | 2012-04-27 | 2016-05-25 | クミアイ化学工業株式会社 | 農園芸用殺菌剤 |
WO2015034359A2 (en) | 2013-09-04 | 2015-03-12 | Ceradis B.V. | A new antifungal composition for treatment of soil |
US9474282B2 (en) * | 2013-12-13 | 2016-10-25 | Tony John Hall | Acid-solubilized copper-ammonium complexes and copper-zinc-ammonium complexes, compositions, preparations, methods, and uses |
EP3681949A4 (en) | 2017-09-14 | 2021-07-14 | 3M Innovative Properties Company | FLUORINATED COPOLYMER AND COMPOSITIONS AND ARTICLES USING IT |
-
2013
- 2013-12-13 US US14/106,676 patent/US9474282B2/en active Active
-
2014
- 2014-12-12 RS RS20220718A patent/RS63448B1/sr unknown
- 2014-12-12 PE PE2016000798A patent/PE20161172A1/es not_active Application Discontinuation
- 2014-12-12 US US15/103,872 patent/US10729139B2/en active Active
- 2014-12-12 JP JP2016539109A patent/JP6808489B2/ja active Active
- 2014-12-12 CA CA2933594A patent/CA2933594C/en active Active
- 2014-12-12 AP AP2016009265A patent/AP2016009265A0/en unknown
- 2014-12-12 MX MX2016007640A patent/MX2016007640A/es unknown
- 2014-12-12 CR CR20160317A patent/CR20160317A/es unknown
- 2014-12-12 BR BR112016013486A patent/BR112016013486A2/pt not_active IP Right Cessation
- 2014-12-12 EA EA201691090A patent/EA201691090A1/ru unknown
- 2014-12-12 KR KR1020167018273A patent/KR102061823B1/ko active IP Right Grant
- 2014-12-12 LT LTEPPCT/US2014/069908T patent/LT3079476T/lt unknown
- 2014-12-12 DK DK14869541.4T patent/DK3079476T3/da active
- 2014-12-12 ES ES14869541T patent/ES2925740T3/es active Active
- 2014-12-12 HR HRP20221027TT patent/HRP20221027T1/hr unknown
- 2014-12-12 PT PT148695414T patent/PT3079476T/pt unknown
- 2014-12-12 CN CN201480072256.1A patent/CN105873442B/zh active Active
- 2014-12-12 HU HUE14869541A patent/HUE059877T2/hu unknown
- 2014-12-12 TN TN2016000237A patent/TN2016000237A1/en unknown
- 2014-12-12 PL PL14869541.4T patent/PL3079476T3/pl unknown
- 2014-12-12 EP EP22176603.3A patent/EP4074318A1/en active Pending
- 2014-12-12 AU AU2014362252A patent/AU2014362252B2/en active Active
- 2014-12-12 EP EP14869541.4A patent/EP3079476B1/en active Active
- 2014-12-12 WO PCT/US2014/069908 patent/WO2015089358A1/en active Application Filing
-
2016
- 2016-06-09 IL IL246143A patent/IL246143A0/en unknown
- 2016-06-09 PH PH12016501103A patent/PH12016501103A1/en unknown
- 2016-06-10 DO DO2016000134A patent/DOP2016000134A/es unknown
- 2016-06-10 NI NI201600080A patent/NI201600080A/es unknown
- 2016-07-11 MA MA39179A patent/MA39179A1/fr unknown
-
2020
- 2020-09-29 JP JP2020162853A patent/JP7089562B2/ja active Active
Patent Citations (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1988752A (en) | 1931-10-03 | 1935-01-22 | Stanco Inc | Copper fungicide |
US2414660A (en) | 1942-06-27 | 1947-01-21 | Tennessee Copper Company | Copper fungicides and process of producing same |
US4048324A (en) | 1973-12-28 | 1977-09-13 | Armand Kohn | Fungicidal composition and method |
EP0136137A2 (en) * | 1983-09-16 | 1985-04-03 | BP Chemicals Limited | Fungicidal compositions |
US4952398A (en) | 1988-03-17 | 1990-08-28 | Jean Tapin | Biocidal composition with copper algicide |
JPH01305013A (ja) | 1988-06-03 | 1989-12-08 | Shinagawa Nenryo Kk | 化粧料用防腐剤 |
US5373025A (en) | 1992-02-24 | 1994-12-13 | Olin Corporation | Sanitizer for swimming pools, spas, and hot tubs |
US6168643B1 (en) * | 1997-01-23 | 2001-01-02 | Safergro Laboratories, Inc. | Inorganic phosphorus fertilizer |
US6340384B1 (en) | 1999-05-24 | 2002-01-22 | Lonza Inc. | Copper/amine oxide wood preservatives |
US7060302B1 (en) | 1999-08-31 | 2006-06-13 | Remedy Research Limited | Metal-containing compositions, preparations and uses |
US20060089342A1 (en) | 2000-06-22 | 2006-04-27 | Gavin David F | Topical anti-microbial compositions |
US6942878B2 (en) | 2000-09-11 | 2005-09-13 | Showa Denko K.K. | Cosmetic composition |
US20040001791A1 (en) * | 2000-11-16 | 2004-01-01 | Zeiler Kenneth T. | Composition, method of use, and devices for the treatment of onychomycosis |
US6896908B2 (en) | 2001-01-30 | 2005-05-24 | U.S. Borax Inc. | Wood preservative concentrate |
US20080004177A1 (en) | 2003-10-17 | 2008-01-03 | Thomas Pfeiffer | Novel Copper-Containing Formulations |
US20090226494A1 (en) | 2005-11-17 | 2009-09-10 | Stephen Spaulding Hickok | Pathogen - controlling products |
US8012511B1 (en) | 2005-12-02 | 2011-09-06 | Contact Marketing Solutions, Llc | Acidic composition of matter for use to destroy microorganisms |
US8067403B2 (en) | 2005-12-12 | 2011-11-29 | Allaccem, Inc. | Methods and systems for preparing an antimicrobial composition |
US20070275101A1 (en) | 2006-02-23 | 2007-11-29 | Lu Helen S | Removable antimicrobial coating compositions and methods of use |
US8287893B2 (en) | 2007-05-18 | 2012-10-16 | Sciessent Llc | Bioactive agrichemical compositions and use thereof |
US8273791B2 (en) | 2008-01-04 | 2012-09-25 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially décolletage |
US8293282B2 (en) | 2008-02-12 | 2012-10-23 | Arch Wood Protection, Inc. | Micronized copper-containing compositions useful to mitigate residues on wood surfaces |
US20100015245A1 (en) | 2008-04-24 | 2010-01-21 | Joe Harrison | Combination of Copper Cations with Peroxides or Quaternary Ammonium Compounds for the Treatment of Biofilms |
US20120021911A1 (en) | 2009-03-06 | 2012-01-26 | Gowan Co. | Plant Treatment Compositions and Methods for Their Use |
Non-Patent Citations (15)
Title |
---|
ChemDemos (2012), Copper-Ammonia Complex, pp. 1-3. * |
Gant et al., Letters to the Editor, The Hospital Infection Society, Nov. 14, 2009, pp. 82-84, vol. issue unknown, Elsevier, published on-line. |
Gant et al.,Three novel highly charged copper-based biocides:safety and efficacy against healthcare-associated organisms,Journal of Antimicrobial Chemotherapy,Jun. 13, 2007 . . . pp. 294-299, vol. 60, Oxford University Press. Published on-line. |
Gant, Novel copper-based biocides: efficacy against multiresistant Acinetobacter in an ICU environment, published online Aug. 3, 2007. |
Hall et al, Decontamination of laundry at low temperature with CuWB50, a novel copper-based biocidal compound, American Journal of Infection Control, Aug. 2009, pp. 478-483 . . . vol. 37, No. 6, the Association for Professionals in Infection Control and Epiemiology, Inc., published on-line. |
Hall et al., A hospital cleaning study using microfibre and a novel copper biocide. I. Microbiological studies, Journal of Infection Prevention, Sep. 2011, pp. 188-194, . . . vol. 12, No. 5, Sage Publications, Published on-line. |
Hall et al., A UK district general hospital cleaning study: a comparison of the performance of ultramicrofibre technology with or without addition of a novel copper-based . . . biocide with standard hypochlorite-based cleaning, Journal of Infection Prevention, Nov. 2011, pp. 232-236, vol. 12, No. 6, Sage Publishing, U.K. |
Hall et al., Biocides for laundry decontamination, Focus on Detergency, Feb. 2010, pp. 8-10, vol./issue NA, Household and Personal Care Today. United Kingdom. |
Hall et al., Effect of the dried residues of two hand gels on the survival of meticillin-resistant Staphylococcus aureus and Acinetobacter calcoaceticus-baumannii, . . . Journal of Infection Prevention, May 2010, pp. 70-73, vol. 2, No. 3, Sage Publications, Published on-line. |
Hall et al.,A comparison of the antibacterial efficacy and cytotoxicity to cultured human skin cells of 7 commercial hand rubs and Xgel,a new copper-based biocidal hand rub . . . The American Journal of Infection Control, 2009, pp. 322-326, vol. 37, No. 4, the Association for Professionals in Infection Control and Epidemiology, Inc. Published on-line. |
Hamilton et al., Performance of ultramicrofibre cleaning technology with or without addition of a novel copper-based biocide, Journal of Hospital Infection, Oct. 12, 2009 . . . pp. 62-71, vol. 74, Elsevier, published on-line. |
Labnet Internatinoal, Inc. (2010), Instruction Manual, pp. 1-12. * |
Moore et al., The efficacy of the inorganic copper-based biocide CuWB50 is compromised by hard water, Letters in Applied Microbiology, Feb. 28, 2008, pp. 655-660, vol. 46, . . . The Society for Applied Microbiology, Published on-line. |
Wren et al., Removing bacteria from hospital surafces:a laboratory comparison of ultramicrofibre and standard cloths, Journal of Hospital Infection, Sep. 17, 2008, pp. 265-2. |
Wren et al., Removing bacteria from hospital surfaces:a laboratory comparision of ultramicrofibre and standard cloths, Journal of Hospital Infection, Sep. 17, 2008, vol. 70 . . . pp. 265-271, Elsevier Ltd., Published on-line. |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160309722A1 (en) * | 2013-12-13 | 2016-10-27 | Myco Sciences Limited | Acid-solubilized copper-ammonium complexes and copper-zinc ammonium complexes, compositions, preparations, methods, and uses |
US10729139B2 (en) * | 2013-12-13 | 2020-08-04 | Myco Sciences Limited | Acid-solubilized copper-ammonium complexes and copper-zinc ammonium complexes, compositions, preparations, methods, and uses |
US11395492B2 (en) | 2015-06-08 | 2022-07-26 | Vm Agritech Limited | Antimicrobial and agrochemical compositions |
WO2019079912A1 (es) * | 2017-10-25 | 2019-05-02 | Compañia Minera San Geronimo | Método para el control de hongos y bacterias en osamentas y anatomía patológica; método para la desinfección y sanitización de ambientes y/o superficies contaminados; y usos |
US11596705B2 (en) * | 2017-10-27 | 2023-03-07 | Onelife S.A. | Kit for detecting residual contaminations on medical devices |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7089562B2 (ja) | 酸可溶性銅-アンモニウム錯体および銅-亜鉛-アンモニウム錯体、組成物、調製、方法、ならびに使用 | |
Borkow et al. | Copper, an ancient remedy returning to fight microbial, fungal and viral infections | |
Borkow | Using copper to fight microorganisms | |
JP5693470B2 (ja) | 銀イオンおよびメントールを含む消毒剤組成物並びにその使用 | |
CA2495938C (en) | A wide spectrum disinfectant | |
WO2006029351A2 (en) | Antiseptic compositions and methods of use | |
WO2006029278A2 (en) | Phenolic antiseptic compositions and methods of use | |
JP2017513951A (ja) | フッ化カルシウムを基礎とする改良された殺生物剤組成物及びその使用 | |
WO2019171385A1 (en) | Preservation of personal care compositions | |
JP2540777B2 (ja) | 液状消毒剤 | |
OA17904A (en) | Acid-solubilized copper-ammonium complexes and copper-zinc-ammonium complexes, compositions, preparations, methods, and uses. | |
JP2019509353A (ja) | 微生物バイオフィルムに関連する皮膚状態および疾患の処置 | |
RU2393851C2 (ru) | Дерматологическая композиция | |
WO2007027118A1 (fr) | Composition dermatologique | |
Fahad et al. | Preparation and studying of the physiochemical properties and antimicrobial activity of new triple-action glass cleaners | |
WO2023007399A1 (en) | Antimicrobial compositions comprising edta, alcohol and chlorhexidine and use thereof on biofilms cells | |
RO127727B1 (ro) | Preparate farmaceutice, de tip discuri bioadezive, pe bază de complecşi metalici ai clorhexidinei, şi procedeu de obţinere a acestora | |
RO127722B1 (ro) | Preparate farmaceutice, de tip apă de gură, pe bază de complecşi metalici ai clorhexidinei şi procedeu de obţinere a acestora |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: LAKESIDE HOLDINGS, LLC, KENTUCKY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HALL, TONY JOHN;REEL/FRAME:034283/0037 Effective date: 20141127 |
|
AS | Assignment |
Owner name: MYCO SCIENCES LIMITED, UNITED KINGDOM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LAKESIDE HOLDINGS, LLC;REEL/FRAME:038270/0312 Effective date: 20160411 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FEPP | Fee payment procedure |
Free format text: SURCHARGE FOR LATE PAYMENT, SMALL ENTITY (ORIGINAL EVENT CODE: M2554); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 4 |
|
AS | Assignment |
Owner name: VM AGRITECH LIMITED, UNITED KINGDOM Free format text: CHANGE OF NAME;ASSIGNOR:MYCO SCIENCES LIMITED;REEL/FRAME:057620/0312 Effective date: 20210222 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2552); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 8 |